CN104922383B - 一种改善心肌缺血及心律失常的组合物 - Google Patents
一种改善心肌缺血及心律失常的组合物 Download PDFInfo
- Publication number
- CN104922383B CN104922383B CN201510324151.7A CN201510324151A CN104922383B CN 104922383 B CN104922383 B CN 104922383B CN 201510324151 A CN201510324151 A CN 201510324151A CN 104922383 B CN104922383 B CN 104922383B
- Authority
- CN
- China
- Prior art keywords
- weight portion
- compositions
- crude drug
- fine powder
- vitis viniferae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 208000031225 myocardial ischemia Diseases 0.000 title claims description 8
- 239000003814 drug Substances 0.000 claims abstract description 37
- 210000000582 semen Anatomy 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 23
- 235000009392 Vitis Nutrition 0.000 claims abstract description 19
- 241000219095 Vitis Species 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 17
- 241000628997 Flos Species 0.000 claims abstract description 15
- 235000003935 Hippophae Nutrition 0.000 claims abstract description 14
- 241000229143 Hippophae Species 0.000 claims abstract description 14
- 239000002671 adjuvant Substances 0.000 claims abstract description 11
- 239000002775 capsule Substances 0.000 claims abstract description 11
- 230000008569 process Effects 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 10
- 239000008187 granular material Substances 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims abstract description 9
- 239000006187 pill Substances 0.000 claims abstract description 9
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 239000003826 tablet Substances 0.000 claims abstract description 7
- 244000269722 Thea sinensis Species 0.000 claims description 10
- 235000013616 tea Nutrition 0.000 claims description 6
- 235000009569 green tea Nutrition 0.000 claims description 5
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 4
- 240000005385 Jasminum sambac Species 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 21
- 230000036407 pain Effects 0.000 abstract description 21
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 10
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 8
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 206010041591 Spinal osteoarthritis Diseases 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 10
- 241000700159 Rattus Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 7
- 210000003462 vein Anatomy 0.000 description 5
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 4
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- 210000001185 bone marrow Anatomy 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 3
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 3
- 241000207840 Jasminum Species 0.000 description 3
- 241000700157 Rattus norvegicus Species 0.000 description 3
- 229940039750 aconitine Drugs 0.000 description 3
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000002861 ventricular Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 2
- 206010033425 Pain in extremity Diseases 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 206010034464 Periarthritis Diseases 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 208000007613 Shoulder Pain Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- RHAXKFFKGZJUOE-UHFFFAOYSA-N 7-acetyl-6-ethyl-3,5,8-trihydroxy-9,10-dioxoanthracene-1,2-dicarboxylic acid Chemical compound O=C1C2=CC(O)=C(C(O)=O)C(C(O)=O)=C2C(=O)C2=C1C(O)=C(CC)C(C(C)=O)=C2O RHAXKFFKGZJUOE-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010037779 Radiculopathy Diseases 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 231100000824 inhalation exposure Toxicity 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别(mg/kg) | 动物数(只) | 存活时间(分) |
对照组 | 10 | 42.14±10.69 |
本发明组 | 10 | 86.19±12.21 |
组别(mg/kg) | 动物数 | 室颤动物数 | 室颤率% |
对照组 | 10 | 9 | 90% |
本发明组 | 10 | 1 | 10% |
组别 | N | LDH(U/L) | MDA(nmol/ml) | SOD(U/ml) |
对照组 | 13 | 8603.12±1463.82 | 2.75±0.78 | 94.81±9.65 |
模型组 | 13 | 10532.62±1245.19 | 4.96±1.56 | 76.65±8.12 |
本发明组 | 14 | 9058.52±1563.37 | 2.85±0.81 | 91.69±9.69 |
组别 | 治疗人数 | 治愈 | 显效 | 有效 | 无效 | 总有效率 |
治疗组 | 100 | 69 | 20 | 10 | 1 | 99% |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510324151.7A CN104922383B (zh) | 2015-06-12 | 2015-06-12 | 一种改善心肌缺血及心律失常的组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510324151.7A CN104922383B (zh) | 2015-06-12 | 2015-06-12 | 一种改善心肌缺血及心律失常的组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104922383A CN104922383A (zh) | 2015-09-23 |
CN104922383B true CN104922383B (zh) | 2016-10-19 |
Family
ID=54110032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510324151.7A Active CN104922383B (zh) | 2015-06-12 | 2015-06-12 | 一种改善心肌缺血及心律失常的组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104922383B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106138970A (zh) * | 2016-08-26 | 2016-11-23 | 闫福林 | 一种治疗心律不齐的中药组合物 |
CN110368444A (zh) * | 2019-08-30 | 2019-10-25 | 屈凤军 | 一种通经络通气血的中成药及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1583068A (zh) * | 2004-06-08 | 2005-02-23 | 上海交大昂立股份有限公司 | 一种具有调节血糖、调节免疫功能的保健食品 |
CN101653181B (zh) * | 2007-04-18 | 2012-03-21 | 广西巴马常春藤生命科技发展有限公司 | 一种保健茶及其加工工艺 |
-
2015
- 2015-06-12 CN CN201510324151.7A patent/CN104922383B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104922383A (zh) | 2015-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104922383B (zh) | 一种改善心肌缺血及心律失常的组合物 | |
CN104940704A (zh) | 一种治疗颈肩腰腿痛的中药组合物 | |
CN104367757A (zh) | 一种治疗颈肩腰腿痛的中药组合物 | |
CN104367921A (zh) | 一种治疗颈肩腰腿痛的中药组合物 | |
CN104189819B (zh) | 一种用于调理情绪健康的中药制剂 | |
CN105395600A (zh) | 一种青钱柳提取物在制备治疗心脑血管疾病药物中的应用 | |
CN104825786A (zh) | 一种治疗颈肩腰腿痛的中药组合物 | |
CN105688051A (zh) | 一种治疗颈肩腰腿痛的中药组合物 | |
CN104306649B (zh) | 一种治疗带状疱疹的药剂 | |
CN105535643A (zh) | 一种治疗颈肩腰腿痛的中药组合物 | |
CN110507796A (zh) | 一种治疗多种疾病的中药配方 | |
CN110339323A (zh) | 一种治疗心动过缓的中药组合物及其制备方法和应用 | |
CN103550631B (zh) | 一种治疗肌肉酸痛的药剂 | |
CN102274336B (zh) | 一种治疗类风湿性关节炎的药物组合物 | |
CN102416147B (zh) | 一种治疗戒毒人员的躁狂症的药物组合物 | |
CN106420926A (zh) | 一种治疗鼻窦炎的药物及其制备方法 | |
CN106038901A (zh) | 一种治疗颈肩腰腿痛的中药组合物 | |
CN100406035C (zh) | 一种治疗腰椎间盘突出症的中药制剂 | |
CN105641353A (zh) | 一种治疗颈肩腰腿痛的中药组合物 | |
CN1318049C (zh) | 一种治疗银屑病的药物 | |
CN105311065A (zh) | 一种通经草提取物在制备治疗心脑血管疾病药物中的应用 | |
CN105902918A (zh) | 一种治疗颈肩腰腿痛的中药组合物 | |
CN104225435A (zh) | 一种治疗痰浊壅阻型冠心病的中药制剂 | |
CN104324282A (zh) | 一种治疗肌肉酸痛的药剂的制备方法 | |
CN105012709B (zh) | 用于痿症的补肾温阳丸 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190411 Address after: 100068 Beijing Fengtai District Caoqiao Xinyuan 3 District 1 Building 6 Unit 13 1 Patentee after: Peng Gao Address before: 100037 No. 34 Zengguang Road, Haidian District, Beijing, No. 1 Building, 8th Floor 807 Patentee before: Beijing Kangzhou Runfa High Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230524 Address after: 807, 8th floor, Building 19, Dongguoyuan, Tongzhou District, Beijing, 101117 Patentee after: Beijing Kangzhou Runfa High Technology Co.,Ltd. Address before: 100068 Beijing Fengtai District Caoqiao Xinyuan 3 District 1 Building 6 Unit 13 1 Patentee before: Peng Gao |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240112 Address after: 102200, 8, Zhenxing Road, Changping District science and Technology Park, Beijing Patentee after: BEIJING ASIA-EAST BIO-PHARMACEUTICAL Co.,Ltd. Address before: 807, 8th floor, Building 19, Dongguoyuan, Tongzhou District, Beijing, 101117 Patentee before: Beijing Kangzhou Runfa High Technology Co.,Ltd. |